宫瘤宁胶囊对气滞血瘀证子宫肌瘤瘤体的抑制作用

杜亚青; 贾林燚; 赵爱民; 董润之

doi:10.13422/j.cnki.syfjx.2016240177

您当前的位置：

首页 >

文章列表页 >

宫瘤宁胶囊对气滞血瘀证子宫肌瘤瘤体的抑制作用

临床 | 更新时间：2024-01-04

- 宫瘤宁胶囊对气滞血瘀证子宫肌瘤瘤体的抑制作用
- Inhibitory Effect of Gongliuning Capsules Combined with Mifepristone on Hysteromyoma with Stagnation of Qi and Blood
- 中国实验方剂学杂志 2016年22卷第24期页码：177-181
- 作者机构：
- 作者简介：
- 基金信息：
  
  邢台市科技局医学卫生基金（2014WS0528）
- DOI：10.13422/j.cnki.syfjx.2016240177
  中图分类号： R737.33
- 纸质出版日期：2016
- 稿件说明：
移动端阅览
杜亚青, 贾林燚, 赵爱民, 等. 宫瘤宁胶囊对气滞血瘀证子宫肌瘤瘤体的抑制作用[J]. 中国实验方剂学杂志, 2016,22(24):177-181.

DU Ya-qing, JIA Lin-yi, ZHAO Ai-min, et al. Inhibitory Effect of Gongliuning Capsules Combined with Mifepristone on Hysteromyoma with Stagnation of Qi and Blood[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(24): 177-181.
杜亚青, 贾林燚, 赵爱民, 等. 宫瘤宁胶囊对气滞血瘀证子宫肌瘤瘤体的抑制作用[J]. 中国实验方剂学杂志, 2016,22(24):177-181. DOI： 10.13422/j.cnki.syfjx.2016240177.

DU Ya-qing, JIA Lin-yi, ZHAO Ai-min, et al. Inhibitory Effect of Gongliuning Capsules Combined with Mifepristone on Hysteromyoma with Stagnation of Qi and Blood[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(24): 177-181. DOI： 10.13422/j.cnki.syfjx.2016240177.

摘要

目的：评价宫瘤宁胶囊联合米非司酮治疗子宫肌瘤气滞血瘀证的临床疗效及对血清中血管内皮生长因子（VEGF），基质金属蛋白酶9（MMP-9），转移生长因子-β1（TGF-β1），表皮生长因子（EGF）表达的影响。方法：将146例患者采用随机按数字表法分为对照组和联合组各73例。对照组采用米非司酮片，月经第1天开始，25 mg·d-1，晨服。联合组在对照组治疗的基础上加用宫瘤宁胶囊，6粒/次，3次/d。两组疗程均为3个月。采用彩超测量治疗前后肌瘤和子宫大小；进行治疗前后气滞血瘀证评分；检测治疗前后促卵泡刺激素（FSH），促黄体生成素（LH），雌二醇（E2）和孕激素（P）水平；检测治疗前后VEGF，MMP-9，TGF-β1和EGF水平；随访6个月，记录复发情况。结果：联合组临床疗效总有效率为92.31%，高于对照组的78.13%（P<0.05）；治疗后联合组肌瘤和子宫体积小于对照组，气滞血瘀证评分低于对照组（P<0.01）；治疗后联合组E2，P，FSH，LH水平均低于对照组（P<0.01）；治疗后联合组VEGF，MMP-9，TGF-β1和EGF水平均低于对照组（P<0.01）；联合组复发率24.62%，低于对照组的48.44%（P<0.01）。结论：宫瘤宁胶囊联合米非司酮治疗气滞血瘀型子宫肌瘤在缩小瘤体，改善症状，提高临床疗效，降低复发率方面均优于单纯的米非司酮治疗，其作用机制可能与下调性激素水平，调节VEGF，MMP-9，TGF-β1和EGF等因子的表达有关。

Abstract

Objective: To evaluate the clinical efficacy of Gongliuning capsules combined with mifepristone in treating hysteromyoma (stagnation of Qi and blood) and their effect on vascularendothelial growth factor (VEGF)

matrix metalloproteinase-9 (MMP-9)

transforming growth factor-β1 (TGF-β1) and epidermal growth factor (EGF). Method: One hundred and forty-six patients were divided into control group (73 cases) and combination group (73 cases) by random number table. Patients in control group received mifepristone tablets in the morning

menstruation begins first days

25 mg/day. In addition to the therapy of control group

patients in combination group were also given Gongliuning capsule

6 grains/time

tid. The courses of treatment were 3 months. Before and after treatment

sizes of fibroid and uterus were detected by color doppler ultrasound. Scores of stagnation of Qi and blood were evaluated. Levels of follicle-stimulating hormone (FSH)

luteinizing hormone (LH)

estradiol (E2)

progesterone (P)

VEGF

MMP-9

TGF-β1 and EGF were detected. Recurrence was recorded during the 6-month follow-up visit. Result: The total clinical therapy in observation group was 92.31%

which was superior to 78.13% in control group (P<0.05). After treatment

sizes of fibroid and uterus in combination group were smaller than those in control group

and scores of stagnation of Qi and blood were lower than those in control group (P<0.01). Levels of E2

FSH

VEGF

MMP-9

TGF-β1 and EGF were lower than those in control group (P<0.01). And recurrence rate in combination group was 24.62%

which was lower than 48.44% in control group (P<0.01). Conclusion: The effect of Gongliuning capsules combined with mifepristone was better than mifepristone in treating hysteromyoma (stagnation of Qi and blood)

ameliorating symptoms

improving clinical effect

and reducing recurrence rate

and the mechanism of action may be correlated with decrease in levels of sex hormone

and regulation of the expressions of VEGF

MMP-9

TGF-β1 and EGF factors.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

溃结饮对UC大鼠血清EGF含量的影响

肌瘤清胶囊对子宫肌瘤模型大鼠血清NOS、TNF-α和IL-2水平的影响

普胃丸对慢性胃溃疡大鼠胃组织中EGF和EGFR蛋白表达的影响

参七消痞颗粒对慢性萎缩性胃炎大鼠血清GH,EGF,GAS的影响